Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  momelotinib
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: GS-US-352-0101, NCI-2013-02398, 2013-002707-33, NCT01969838
Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: GS-US-370-1296, NCI-2014-02652, NCT02101021
Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Metastatic Non-Small Cell Lung Cancer (NSCLC)
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GS-US-370-1298, NCI-2014-02232, NCT02206763
Start Over